Search - tctmd.com

Displaying 161 - 180 of 1941

Sort: Relevancy | Date

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

Caitlin E. Cox

December 10, 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

Lipid Fluctuations Over Time May Portend Dementia: ASPREE

Yael L. Maxwell

November 15, 2024

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

News Daily News

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

Caitlin E. Cox

November 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

One-Year Clinical Outcomes of T-TEER Versus TTVR Among High-Risk Patients With Symptomatic Tricuspid Regurgitation: A Propensity-Score Matched Analysis

Presenter: Guido Ascione

October 29, 2024

Advertisement

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Female-Specific Factors Don’t Enhance Common Risk Calculators

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Lipid Fluctuations Over Time May Portend Dementia: ASPREE

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

One-Year Clinical Outcomes of T-TEER Versus TTVR Among High-Risk Patients With Symptomatic Tricuspid Regurgitation: A Propensity-Score Matched Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content